Silva Filho LVRF, Castaños C, Ruíz HH. Cystic fibrosis in Latin America improving the awareness. J Cyst Fibros. 2016;15:791–3.
Article
Google Scholar
Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45–56.
Article
CAS
Google Scholar
Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A, et al. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles. J Med Genet. 2017;54:224–35.
Article
CAS
Google Scholar
Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Testino G, Truglio G. The impact on genetic testing of mutational patterns of CFTR gene in different clinical macrocategories of cystic fibrosis. J Mol Diagn. 2016;18:554–65.
Article
CAS
Google Scholar
Chávez-Saldaña M, Yokoyama E, Lezana JL, Carnevale A, Macías M, Vigueras RM, et al. CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: implications for molecular screening. Rev Investig Clin. 2010;62:546–52.
Google Scholar
Nunes LM, Ribeiro R, Niewiadonski VDT, Sabino E, Yamamoto GL, Bertola DR, et al. A new insight into CFTR allele frequency in Brazil through next generation sequencing. Pediatr Pulmonol. 2017;52:1300–5.
Article
Google Scholar
Pepermans X, Mellado S, Chialina S, Wagener M, Gallardo L, Lande H, et al. Identification and frequencies of cystic fibrosis mutations in Central Argentina. Clin Biochem. 2016;49:154–60.
Article
CAS
Google Scholar
Riordan JR, Rommens JM, Kerem B, NO a A, Rozmahel R, Grzelczak Z, et al. Identification the cystic fibrosis Gene : cloning and characterization of complementary DNA. Science. 1989;245:1066–73.
Article
CAS
Google Scholar
Ivanov M, Matsvay A, Glazova O, Krasovskiy S, Usacheva M, Amelina E, et al. Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis. BMC Med Genet. 2018;11:13.
Google Scholar
White MB, Leppert M, Nielsen D, Zielenski J, Gerrard B, Stewart C, et al. A de novo cystic fibrosis mutation: CGA (Arg) to TGA (stop) at codon 851 of the CFTR gene. Genomics. 1991;11:778–9.
Article
CAS
Google Scholar
Cremonesi L, Cainarca S, Rossi A, Padoan R, Ferrari M. Detection of a de novo R1066H mutation in an Italian patient affected by cystic fibrosis. Hum Genet. 1996;98:119–21.
Article
CAS
Google Scholar
Casals T, Ramos MD, Giménez J, Nadal M, Nunes V, Estivill X. Paternal origin of a de novo novel CFTR mutation (L1065R) causing cystic fibrosis. Hum Mutat. 1988;(Suppl 1):S99-102.
Křenková P, Piskáčková T, Holubová A, Balaščaková M, Krulišová V, Čamajová J, et al. Distribution of CFTR mutations in the Czech population: positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations. J Cyst Fibros. 2013;12:532–7.
Article
Google Scholar
Girodon E, Des georges M, Medina R, Grenet D, Férec C, Claustres M, et al. Ocurrence of CFTR de novo mutations is not so rare. J Cyst Fibros. 2008;7:S6.
Article
Google Scholar
Norek A, Stremska M, Sobczyńska-Tomaszewska A, Wertheim-Tysarowska K, Dmeńska H, Jurek M. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype. J Pediatr. 2011;159:343–6.
Article
Google Scholar
Orozco L, Velázquez R, Zielenski J, Tsui LC, Chávez M, Lezana JL, Saldaña Y, Hernández E, Carnevale A. Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1089C, 846delT, P750L, 4160insGGGG and 297-1G--A). Hum Genet. 2000;106:360–5.
Article
CAS
Google Scholar
Bergougnoux A, D'Argenio V, Sollfrank S, Vermeau F, Telese A, et al. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology. Clin Chem Lab Med. 2018;56:1046–53.
Article
CAS
Google Scholar
Dequeker E, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendations. Eur J Hum Genet. 2009;17:51–65.
Article
CAS
Google Scholar
Friedman KJ, Edward Highsmith W, Silverman LM. Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem. 1991;37:753–5.
CAS
PubMed
Google Scholar
Orozco L, Friedman K, Chávez M, Lezana JL, Villareal MT, Carnevale A. Identification of the I507 deletion by site-directed mutagenesis. Am J Med Genet. 1994;15:137–9.
Article
Google Scholar
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17:1–14.
Article
Google Scholar
Claustres M, Thèze C, des Georges M, Baux D, Girodon E, Bienvenu T, et al. CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants. Hum Mutat. 2017;38:1297–315.
Article
CAS
Google Scholar
Lucarelli M, Porcaro L, Biffignandi A, Costantino I, Gionnone V, et al. A new targeted CFTR mutation panel based on next-generation sequencing technology. J Mol Diagn. 2017;19:788–800.
Article
CAS
Google Scholar
Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565–75.
Article
CAS
Google Scholar
Shoshanl T, Augarten A, Yahav J, Gazit E, Kerem B. Two novel mutations in the CFTR gene: W1089X in exon 17B and 4010delTATT in exon 21. Hum Mol Genet. 1994;3:657–8.
Article
Google Scholar
Kellermayer R. Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet. 2006;49:445–50.
Article
Google Scholar
Hinzpeter A, Reboul MP, Callebaut I, Zordan C, Costes B, Guichoux J, et al. The importance of functional test to assess the effect of a new CFTR variant when genotype-phenotype correlation is not possible. Clin Case Rep. 2017;5:658–63.
Article
Google Scholar
Altamura N, Castaldo R, Finotti A, Breveglieri G, Salvatori F, et al. Tobramycin is a suppressor of premature termination codons. J Cyst Fibrosis. 2013;12:806–11.
Article
CAS
Google Scholar
Girard SL, Bourassa CV, Lemieux Perreault L-P, Legault M-A, Barhdadi A, Ambalavanan A, et al. Paternal age explains a major portion of De novo germline mutation rate variability in healthy individuals. PLoS One. 2016;11:e0164212.
Article
Google Scholar
Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Al Turki S, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48:126–33.
Article
CAS
Google Scholar